BlackRock Health Sciences Term Trust

Frequently Asked Questions About BMEZ

What does BMEZ invest in?

BlackRock Health Sciences Term Trust is a closed-end management investment company, which investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The company was founded on August 14, 2019 and is headquartered in Wilmington, DE.

What is the expense ratio of BMEZ?

BlackRock Health Sciences Term Trust (BMEZ) charges an expense ratio of 1.36%. This is the annual fee deducted from fund assets to cover management and operations.

How big is BMEZ?

BlackRock Health Sciences Term Trust (BMEZ) manages $1.53B in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure — funds below ~$50M are at higher risk of liquidation.

Is BMEZ actively managed or an index fund?

BMEZ's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy.

When was BMEZ launched?

BlackRock Health Sciences Term Trust (BMEZ) launched in January 2020 and is managed by BlackRock / iShares.

How has BMEZ performed?

BMEZ's total return — price change plus reinvested distributions — is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.